intramedullary spinal cord tumor
Conditions
Interventions
experimental group:continuously infuse cisatracurium
Sponsors
Beijing Tsinghua Changgung Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1. Intramedullary spinal cord tumor resection under general anesthesia and TceMEP monitoring are planned to be performed in our hospital at an selected time; 2. Aged between 18 and 65 years, regardless of gender; 3. ASA grade: I-II; 4. Voluntarily participate in clinical trials and sign informed consent.
Exclusion criteria
Exclusion criteria: 1. Patients with severe heart disease, respiratory dysfunction, and abnormal liver and kidney function; 2. Patients complicated with severe neuromuscular diseases before surgery; 3. Patients who already had severe limb movement disorder before surgery (muscle strength grade 3 and below); 4. Continuous loss of MEP signal during operation due to other reasons or clear new limb movement disorders found in postoperative follow-up; 5. Patients with previous allergy to cis-atracurium were identified; 6. Patients with a history of epilepsy, cardiac pacemaker installation, intracranial metal implant or skull fracture and other motor evoked potential contraindications; 7. The surgeon or researcher considers it unsuitable to participate in the study; 8. Continued treatment in ICU after surgery; 9. The patient cannot understand or cooperate with the study and refuses to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Whether motor evoked potentials can be successfully monitored; | — |
Countries
China
Contacts
Public ContactHuan Zhang
Beijing Tsinghua Changgung Hospital
Outcome results
None listed